Effect of Genetic Risk Factors and Disease Progression on the Cerebrospinal Fluid Tau Levels in Alzheimer's Disease
Data up to Jan 2025
Total Citations Per Year
Abstract
References (20)
Clinical diagnosis of Alzheimer's disease
1984 • 27,279 citations
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
1993 • 8,888 citations
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
1995 • 3,985 citations
Candidate Gene for the Chromosome 1 Familial Alzheimer's Disease Locus
1995 • 2,548 citations
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
1991 • 1,397 citations
Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
1988 • 899 citations
Tau protein and the neurofibrillary pathology of Alzheimer's disease
1993 • 710 citations
Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
1995 • 684 citations
Alzheimer–associated presenilins 1 and 2 : Neuronal expression in brain and localization to intracellular membranes in mammalian cells
1996 • 549 citations
Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay
1993 • 481 citations
A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism
1995 • 337 citations
Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease
1995 • 296 citations
Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease
1996 • 244 citations
Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease
1995 • 223 citations
Increased cerebrospinal fluid tau in patients with Alzheimer's disease
1995 • 134 citations
Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele ϵ4 during 14 months follow-up
1996 • 69 citations
Presenilin-1 polymorphism and Alzheimer's disease
1996 • 66 citations
Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain
1996 • 45 citations
Apolipoprotein E and α1‐antichymotrypsin polymorphism in Alzheimer's disease
1996 • 36 citations
?1-Antichymotrypsin gene polymorphism and risk for Alzheimer's disease
1996 • 33 citations